In transplant and CKD, there is no harmless gap in therapy.
Immunosuppression after transplant and the therapies that slow chronic kidney disease both demand consistency. A lapsed refill, a stalled prior authorization, or a cost barrier can put a graft at risk or speed a patient's decline. Fairview Pharmacy holds an EQuIPP star rating of 5.00 from Elevate Provider Network, Quarter 4, 2025, and we keep complex nephrology regimens on schedule.
What is on the line
In nephrology, every interruption in therapy carries a real cost.
After a transplant, a missed immunosuppressant refill can allow rejection to begin; late graft loss is more often an adherence failure than a surgical one. In chronic kidney disease, when SGLT2 inhibitors and kidney protective therapy lapse, eGFR decline can accelerate and the slide toward dialysis moves faster. And prior authorizations and high copays stall nephrology refills routinely; a patient who cannot afford therapy often simply stops, and you find out from the labs.
A chain pharmacy hands the patient their bottles and moves on. Consistency is nobody's job there. For a transplant or advanced CKD patient, that is not good enough.
Nephrology specific risk
Every delayed prior authorization, every lapsed refill, every cost barrier.
Immunosuppression gaps after transplant
A missed immunosuppressant refill can allow rejection to begin. Graft loss is associated with adherence failure as often as with surgical cause. The window is short, often days.
CKD therapy lapses
When SGLT2 inhibitors and kidney protective therapy lapse, eGFR decline is associated with acceleration, and the progression toward dialysis can move faster.
Prior authorization and cost barriers
Prior authorizations and high copays stall nephrology refills. A patient who cannot afford therapy may stop entirely, and the interruption shows up in the labs before it shows up anywhere else.
In nephrology, adherence is part of the treatment. A pharmacy that lets the regimen lapse is working against the kidney function you are trying to protect.
The liability between you and your patient
At a chain pharmacy, your transplant or CKD patient is a number, and consistency is nobody's job.
If an immunosuppressant refill lapses, nobody calls. If a prior authorization stalls, nobody fights it. If cost becomes the barrier, nobody helps. You find out from a rejection episode or a sharp drop in eGFR.
That is not a pharmacy partner. That is a liability sitting between you and your patient's kidney.
EQuIPP verified, all four measures published
Fairview closed 2025 with blood pressure adherence at 98.2%, 215 of 219 patients, five stars.
EQuIPP star measures, Elevate Provider Network. Quarter 4, 2025, closed measurement year.
- Blood pressure (RASA) PDC98.2%, 215 of 219 patients5 stars
- Cholesterol PDC97.2%, 246 of 253 patients5 stars
- Statin use in diabetes96.3%, 52 of 54 patients5 stars
- Diabetes PDC95.6%, 108 of 113 patients5 stars
EQuIPP star rating 5.00. Five stars on all four measures, every year since 2022.
Fairview's EQuIPP star measure performance, issued by Elevate Provider Network for the closed 2025 measurement year: Blood pressure (RASA) PDC 98.2%, 215 of 219 patients. Cholesterol PDC 97.2%, 246 of 253. Statin use in diabetes 96.3%, 52 of 54. Diabetes PDC 95.6%, 108 of 113. EQuIPP star rating 5.00. Five stars on all four measures, every year since 2022. For your transplant and CKD patients, that discipline means immunosuppression refilled on schedule, every refill on time, and a pharmacist who calls the moment cost threatens the graft or the kidney.
EQuIPP performance metrics as of Quarter 4, 2025, Medicare Part D population, benchmarked against national pharmacy averages. These measures describe prescribing and dispensing patterns. Neither is a measure of health outcomes.
You prescribe.
E prescribe to Fairview. NCPDP 2515104, NPI 1144383613.
We fill same day.
We clear every prior authorization.
We monitor.
We watch for on schedule refills and call before any dose is missed.
We report to you.
Refill and adherence updates on the patients you referred.
You reinforce.
You address adherence at the next visit.
Same day fills
Every immunosuppressant and nephrology prescription filled within 24 hours.
100% prior authorization handling
We fight and appeal every transplant and CKD prior authorization.
On schedule refill calls
We reach patients before an immunosuppressant dose is missed.
Refill synchronization
Transplant and CKD medications coordinated into one refill schedule.
Cost and copay support
We find savings programs so cost is less likely to end therapy.
Adherence reports to you
Who is filling and who is not, delivered to your office at day ninety.
Start with 5, zero risk
Send us 5 of your transplant or advanced CKD patients. 90 days. Zero risk.
We resolve the prior authorizations, keep every refill on schedule, and report adherence back to your office. No contract, no cost, and nothing owed in either direction. If the reports are not useful, tell us and we will change the format.
Request your intro call
A 10 minute call with Dr. Mike, no commitment and no paperwork to start. Just tell us how to reach you and a little about your practice. The 5 patient pilot is what we walk through on the call.
Typical response: Within 1 business day
Forms for referring practices